Document is current
Any future updates will be listed below
-
Authors
Dörner, Thomas https://orcid.org/0000-0002-6478-7725
Lipsky, Peter E. https://orcid.org/0000-0002-9287-1676
- License Information
-
More Information
Article History
Accepted: 2 October 2024
First Online: 7 November 2024
Competing interests
: T.D. declares honoraria for scientific advice from Abelzeta, BMS, Janssen, Novartis, Roche/GNE and UCB, and fees for clinical studies (paid to the university) by BMS, Novartis, Eli Lilly & Company, Janssen and Roche. P.E.L. is co-founder of AMPEL Biosolutions and an adviser to Abelzeta.
